GGrantIndex
← Leaderboards

Thomas Neumann

Visiongate, Inc.

$12,195,071
Attributed
$12,195,071
Total exposure
12
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3M · FY200523
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$12,195,071 · 12

By mechanism

R44$7,967,612 · 5
RC3$2,621,703 · 1
R43$881,214 · 4
R41$365,000 · 1
R21$359,542 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Cells

Research focus

CellsDesignIn Vitro ModelIn VivoPerformancePharmaceutical PreparationsTechnologyIn VitroOrganSuccessProtocols DocumentationLiquid SubstanceAnimal TestingMicrofluidicsSmall Business Innovation Research GrantTissue EngineeringPerfusionStructureCell TypeRunningScreeningDevicesMicrofluidic MicrochipsPlay

Grant awards (24)

A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds$275,453
R44 · FY2023 · ES · contact PI
Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening$803,596
R44 · FY2022 · ES · contact PI
Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule$1,024,820
R44 · FY2021 · TR · contact PI
Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening$876,058
R44 · FY2021 · ES · contact PI
Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule$1,024,842
R44 · FY2020 · TR · contact PI
Organ-on-Chip Approach for Assessing Tissue-specific SARS-CoV-2 Infection and Response to Antiviral Therapy$255,716
R44 · FY2020 · TR · contact PI
Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening$252,114
R44 · FY2020 · ES · contact PI
Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule$331,413
R44 · FY2019 · TR · contact PI
Organ-on-chip based assays for personalized assessment of renal resilience in aging patients$300,000
R43 · FY2019 · AG · contact PI
A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier$687,731
R44 · FY2017 · NS · contact PI
A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier$700,895
R44 · FY2016 · NS · contact PI
A microfluidic quality-control assay for stem-cell derived therapies$325,000
R41 · FY2016 · TR · contact PI
Microfluidic Platform for Stem Cell Applications$40,000
R41 · FY2016 · TR · contact PI
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test$739,884
R44 · FY2015 · HL · contact PI
A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier$225,000
R44 · FY2015 · NS · contact PI
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test$770,090
R44 · FY2014 · HL · contact PI
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test$159,849
R43 · FY2011 · HL · contact PI
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test$42,507
R43 · FY2011 · HL · contact PI
Development of high-throughput, commercially viable, Cell-CT instrument with init$2,621,703
RC3 · FY2010 · GM · contact PI
Development of an organotypic in-vitro model of the blood-brain barrier$190,632
R43 · FY2010 · NS · contact PI
Development of a Vascularized In-Vitro Model of the Tumor Microenvironment$164,091
R43 · FY2010 · CA · contact PI
Development of a Vascularized In-Vitro Model of the Tumor Microenvironment$24,135
R43 · FY2010 · CA · contact PI
Development of an In-Vitro Angiogenesis System$160,342
R21 · FY2006 · HL · contact PI
Development of an In-Vitro Angiogenesis System$199,200
R21 · FY2005 · HL